Specialty
Care
Diseases related to blood disorders, heart and the cardiovascular system
Advancing Specialized Therapies for Better Health
Menagen is at the forefront of specialty care, addressing complex and chronic conditions with targeted therapies that enhance patient outcomes.
Our Areas of Focus in Specialty Care:
Diabetes
Providing innovative treatments for blood sugar control.
Diabetes
Diabetes mellitus refers to a group of diseases that affect how the body uses blood sugar (glucose). Glucose is an important source of energy for the cells that make up the muscles and tissues. It's also the brain's main source of fuel.
The main cause of diabetes varies by type. But no matter what type of diabetes you have, it can lead to excess sugar in the blood. Too much sugar in the blood can lead to serious health problems.
Chronic diabetes conditions include type 1 diabetes and type 2 diabetes. Potentially reversible diabetes conditions include prediabetes and gestational diabetes. Prediabetes happens when blood sugar levels are higher than normal. But the blood sugar levels aren't high enough to be called diabetes. And prediabetes can lead to diabetes unless steps are taken to prevent it. Gestational diabetes happens during pregnancy. But it may go away after the baby is born.
Dyslipidemia
Addressing lipid disorders to reduce cardiovascular risks.
Dyslipidemia
Dyslipidemia refers to unhealthy levels of one or more kinds of lipid (fat) in your blood.
Your blood contains three main types of lipid:
high-density lipoprotein (HDL)
low-density lipoprotein (LDL)
triglycerides
LDL cholesterol is considered the “bad” type of cholesterol. That’s because it can build up and form clumps or plaques in the walls of your arteries. Too much plaque in the arteries of your heart can cause a heart attack.
HDL is the “good” cholesterol because it helps remove LDL from your blood.
Triglycerides come from the calories you eat but don’t burn right away. Triglycerides are stored in fat cells. They’re released as energy when you need them. If you eat more calories than you burn, though, you can get a buildup of triglycerides.
High LDL and triglyceride levels put you at a higher risk for heart attack and stroke. Low levels of HDL cholesterol are linked to higher heart disease risks.
Dyslipidemia is divided up into primary and secondary types. Primary dyslipidemia is inherited. Secondary dyslipidemia is an acquired condition. That means it develops from other causes, such as obesity or diabetes.
You may hear the term hyperlipidemia used interchangeably with dyslipidemia. But that’s not entirely accurate. Hyperlipidemia refers to high levels of LDL or triglycerides. Dyslipidemia can refer to levels that are either higher or lower than the normal range for those blood fats.
Among the specific types of primary dyslipidemia are:
Familial combined hyperlipidemia. This is the most common inherited cause of both high LDL cholesterol and high triglycerides. If you have familial combined hyperlipidemia, you could develop these problems in your teens or 20s. You’re also at a higher risk for early coronary artery disease, which can lead to a heart attack. Learn more about this condition.
Familial hypercholesterolemia and polygenic hypercholesterolemia. These are both characterized by high total cholesterol. You can calculate your total cholesterol by adding your LDL and HDL levels, along with half of your triglyceride level. A total cholesterol level of under 200 milligrams per deciliter (mg/dL) is best.
Familial hyperapobetalipoproteinemia. This condition means you have high levels of apolipoprotein B, a protein that is part of your LDL cholesterol.
Hyperlipoproteinemia is a condition that can be primary or secondary. If you have this condition, your body has difficulty breaking down LDL cholesterol or triglycerides.
Hyperphosphatemia in CKD
Controlling phosphorus levels in kidney disease patients.
Hyperphosphatemia Management in Patients with Chronic Kidney Disease
Hyperphosphatemia in chronic kidney disease (CKD) patients is a potentially life altering condition that can lead to cardiovascular calcification, metabolic bone disease (renal osteodystrophy) and the development of secondary hyperparathyroidism (SHPT). It is also associated with increased prevalence of cardiovascular diseases and mortality rates. To effectively manage hyperphosphatemia in CKD patients it is important to not only consider pharmacological and nonpharmacological treatment options but also to understand the underlying physiologic pathways involved in phosphorus homoeostasis.
Heart Failure
Enhancing heart function with advanced therapies.
Heart failure
Heart failure occurs when the heart muscle doesn't pump blood as well as it should. When this happens, blood often backs up and fluid can build up in the lungs, causing shortness of breath.
Some heart conditions slowly leave the heart too weak or stiff to fill and pump blood properly. These conditions include narrowed arteries in the heart and high blood pressure.
Proper treatment may improve the symptoms of heart failure and may help some people live longer. Lifestyle changes can improve quality of life. Try to lose weight, exercise, use less salt and manage stress.
But heart failure can be life-threatening. People with heart failure may have severe symptoms. Some may need a heart transplant or a device to help the heart pump blood.
Heart failure also may be called congestive heart failure.
Our Current Brands:
Ezirosy®
Ezetimibe 10 mg/ Rosuvastatin 20 mg
Supporting cholesterol management in dyslipidemia.
Renagen®
Sevelamer Carbonate 800 mg Tablets
A solution for hyperphosphatemia in CKD.
Join Us in Transforming Healthcare
Explore our innovative solutions and become part of a healthier future for patients around the world.